Codiak BioSciences, Inc. / Fundamentals
Income statement
- Net revenue
€28.98M - Cost of goods sold
€0.00 - Gross profit
€28.98M - SG&A expenses
€29.77M - R&D expenses
€61.04M - EBITDA
-€31.36M - D&A
€14.64M - EBIT
-€46.00M - Interest expenses
-€1.79M - EBT
-€33.86M - Tax expenses
-€8.62M - Net income
-€25.23M
Cash flow statement
- Net deferred tax
-€20.71M - Non-cash items
€14.10M - Changes in working capital
-€28.62M - Operating cash flow
-€57.89M - Capex
€598.95K - Other investing cash flow
€0.00 - Net investing cash flow
-€598.95K - Total cash dividends paid
€0.00 - Issuance of common stock
-€32.21M - Debt repayment
€0.00 - Other financing cash flow
€18.08M - Net financing cash flow
€18.08M - Foreign exchange effects
€0.00 - Net change in cash
-€21.73M - Cash at end of period
€48.27M - Free cash flow
-€57.29M
Balance sheet
- Cash and cash equivalents
€44.67M - Cash and short-term investments
€44.67M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€8.17M - Total current assets
€52.85M - Property, plant & equipment
€35.81M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€27.33M - Total non-current assets
€63.14M - Total assets
€115.99M - Accounts payable
€1.69M - Short-term debt
€2.60M - Other current liabilities
€7.01M - Total current liabilities
€12.48M - Long-term debt
€28.11M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€26.86M - Total non-current liabilities
€69.92M - Total liabilities
€82.39M - Common stock
€3.45K - Retained earnings
-€310.11M - Other equity
€0.00 - Total equity
€33.60M - Total liabilities and shareholders' equity
€115.99M
Company information
- Market capitalization
€0.00 - Employees
102 - Enterprise Value
-€13.96M
Company ratios
- Gross margin
-
100.0% Much better than peer group: -137.7% - EBITDA margin
-
-108.2% Much better than peer group: -1,441.7% - EBIT margin
-
-158.8% Much better than peer group: -1,533.5% - EBT margin
-
-116.8% Much better than peer group: -1,505.8% - Net margin
-
-87.1% Much better than peer group: -1,448.9% - ROE
-
-75.1% Much better than peer group: -147.6% - ROA
-
-21.8% Much better than peer group: -715.3% - Asset turnover
-
25.0% Much worse than peer group: 264.2% - FCF margin
-
-201.9% Much better than peer group: -1,273.6% - FCF yield
0.0% - Efficiency ratio
208.2% - Net sales per employee
-
€284.07K - Net income per employee
-
-€247.36K